Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
Revenues | 3,633 | 3,034 | 3,248 | 3,375 | 3,096 | 2,997 |
Revenue growth | 19.7% | -6.6% | -3.8% | 9.0% | 3.3% | |
Cost of goods sold | 2,926 | 2,495 | 2,555 | 2,599 | 2,361 | 2,365 |
Gross profit | 707 | 539 | 693 | 776 | 735 | 632 |
Gross margin | 19.5% | 17.8% | 21.3% | 23.0% | 23.7% | 21.1% |
Selling, general and administrative | 216 | 260 | 231 | 249 | 249 | 197 |
EBIT | 180 | 220 | 422 | 407 | 372 | 259 |
EBIT margin | 5.0% | 7.3% | 13.0% | 12.1% | 12.0% | 8.6% |
Pre-tax income | 538 | 119 | 346 | 396 | 366 | 250 |
Income taxes | 43 | 39 | 33 | -810 | 1,349 | 51 |
Tax rate | 8.0% | 32.8% | 9.5% | | 368.6% | 20.4% |
Net income | 495 | 80 | 313 | 1,206 | -983 | 199 |
Net margin | 13.6% | 2.6% | 9.6% | 35.7% | -31.8% | 6.6% |
|
Diluted EPS | $1.56 | $1.05 | $4.12 | $16.21 | ($13.27) | $2.69 |
Shares outstanding (diluted) | 318 | 76 | 76 | 74 | 74 | 74 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|